Seelos Therapeutics Inc
NASDAQ:SEEL
Seelos Therapeutics Inc
NASDAQ:SEEL
Price:
0.39
USD
-27.79%
Market Cap:
$100k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Seelos Therapeutics Inc
NASDAQ:SEEL
|
US |
|
Austco Healthcare Ltd
ASX:AHC
|
AU |
|
C
|
Carabao Group PCL
SET:CBG
|
TH |
|
H
|
Hainan Mining Co Ltd
SSE:601969
|
CN |
|
Snipp Interactive Inc
XTSX:SPN
|
CA |
|
C
|
Casino Guichard Perrachon SA
XBER:CAJ
|
FR |
Relative Value
There is not enough data to reliably calculate the relative value of SEEL.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SEEL
Relative Value
Base Case
Not Available
Multiples Across Competitors
SEEL Competitors Multiples
Seelos Therapeutics Inc Competitors
Seelos Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Seelos Therapeutics Inc
NASDAQ:SEEL
|
100k USD | 0 | 0 | 0 | 0 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 27.9 | 15.5 | 21.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.4 | 15.7 | 9.8 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
